- Tips for Spending Holiday Time With Family Members Who Live with Dementia
- Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States
- Check Your Pantry, Lay’s Classic Potato Chips Recalled Due to Milk Allergy Risk
- Norovirus Sickens Hundreds on Three Cruise Ships: CDC
- Not Just Blabber: What Baby’s First Vocalizations and Coos Can Tell Us
- What’s the Link Between Memory Problems and Sexism?
- Supreme Court to Decide on South Carolina’s Bid to Cut Funding for Planned Parenthood
- Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says
- A New Way to Treat Sjögren’s Disease? Researchers Are Hopeful
- Some Abortion Pill Users Surprised By Pain, Study Says
Common Heart Drug Might Lower Anxiety in Kids With Autism
Could a blood pressure drug thats been around since the 1960s help ease anxiety in people with autism?
That’s the main finding from a small study where 69 people between the ages of 7 and 24 who had autism were given the drug, called propranolol.
“The findings show that propranolol could serve as a helpful intervention for reducing anxiety for individuals with autism,” said study lead author Dr. David Beversdorf. He’s a clinician at the University of Missouri’s Thompson Center for Autism and Neurodevelopment.
“This drug has been around since the 1960s and is very inexpensive,” he noted in a university news release. “Up until now, we haven’t had any known drugs that target psychiatric issues specifically for individuals with autism, so these results are very promising and can support future research.”
The study found that people who received propranolol had significantly lower anxiety levels at their three-month checkup.
Although the team also checked participants’ social communication skills, no benefits linked to use of propranolol were found.
Beversdorf said he’s seen firsthand the benefits of propranolol for people with autism who battle anxiety.
“As researchers, we try our best to improve the lives of our patients, and it feels rewarding to help out,” said Beversdorf, who is also a professor of radiology, neurology and psychological sciences at the university. “I went into the field of neurology knowing I wanted to try to find new treatment options and interventions to benefit people with autism.”
The study was published recently in the journal Psychopharmacology.
More information
Find out more about autism at the National Autism Society.
SOURCE: University of Missouri, news release, Jan. 23, 2024
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.